Influenza Vaccine Market 2021 Size & Share | Market worth USD 7.60 Billion at 6.9% CAGR by 2027

Pune, India, Feb. 08, 2021 (GLOBE NEWSWIRE) — According to the report, Influenza Vaccine market size is projected reach USD 7.34 billion by 2026. Global Influenza Vaccine market was USD 11.59 billion in 2018 and is anticipated to exhibit a CAGR of 6.9% during the forecast period set between 2019 to 2026. Influenza Vaccine market in North America was valued at USD 4.05 billion in 2018 and is also expected to observe the highest growth during forecast period.Increasing Demand for Flu Vaccine amid COVID-19 to Aid GrowthThe increasing focus on R&D activities to develop a vaccine to contain the widespread effect of the novel coronavirus is driving the demand for immunization across the globe. The COVID-19 pandemic has brought unprecedented changes in the healthcare industry. An increasing demand for the seasonal influenza vaccine to ensure better protection against the deadly pandemic is anticipated to favor the market growth in the near future.Influenza, also known as flu, is generally a respiratory illness that occurs due to a viral infection. It is highly contagious and mainly spreads through respiratory droplets. In addition to this, it can pass from one person to another through physical contact and while talking. Owing to their serious implications on health, global healthcare organizations such as the Centers for Disease Control and Prevention (CDC) have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients.      The global influenza vaccine market is expected to gain momentum owing to the increasing prevalence of chronic disease and the growing efforts in R&D activities by major companies to develop innovative and effective influenza vaccine treatment during the forecast period.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/influenza-vaccine-market-101896
INDUSTRY DEVELOPMENT:August 2020 – AstraZeneca announced its collaboration with the leading healthcare industry players such as Sanofi, Seqirus, and GlaxoSmithKline to fast-track the manufacturing of its FluMist vaccine to treat influenza and boost its sales for the period, 2020-21.Increasing Prevalence of Influenza to Favor GrowthAccording to the World Health Organization (WHO), seasonal influenza has serious implications for health globally. It is estimated that around 1 billion people are affected by it every year. The increasing prevalence of chronic disease is propelling the manufacturers to develop innovative influenza vaccines. The increasing geriatric population globally is further anticipated to favor the global flu vaccine market during the forecast period. The global healthcare organizations have recommended several licensed vaccines that are being adopted largely to prevent chronic diseases that are propelling the companies to invest in developing innovative vaccines globally. This is expected to bode well for the market growth in the forthcoming years.
The pediatric segment, based on age group, is expected to showcase an exponential growth. This is attributable to the increasing rate of influenza amongst infants and the younger population that is driving the demand for an efficient influenza vaccine.Among all the regions, North America is expected to hold the highest position in the global flu vaccine market. This dominance is attributable to the presence of established companies such as Emergent BioSolutions, Inc. that are increasing their focus on developing advanced influenza vaccines for therapeutic purposes in countries such as the U.S. The region stood at USD 2.18 billion in 2019.
Quick Buy –  Influenza Vaccine Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102958
The global influenza vaccine market is consolidated with the presence of dominating players such as Sanofi that are focusing on upgrading their technology to manufacture advanced flu vaccine and consolidate their positions. The other key players are adopting strategies such as the introduction of new products, collaboration, and partnerships to strengthen their product portfolios and maintain their presence in the global marketplace. For instance, in February 2020, Abbott announced the launch of a new inactivated quadrivalent vaccine for influenza treatment. According to the company, the vaccine received approval for adoption in children below 3 years in India.GlaxoSmithKline plc. (U.K, Europe)Sanofi S.A (France, Europe)AstraZeneca (Cambridge, United Kingdom)Seqirus (Maidenhead, UK)BioDiem (South Melbourne Victoria)Emergent BioSolutions Inc. (Maryland, United States)F. Hoffmann-La Roche Ltd (Basel, Switzerland)Sinovac Biotech Ltd (China)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/influenza-vaccine-market-101896
Global Influenza Vaccine Market Segmentations:By TypeInactivatedLive AttenuatedBy ValencyQuadrivalentTrivalentBy Age GroupPediatricAdultsBy Distribution ChannelHospital & Retail PharmaciesGovernment SuppliersOthersBy Geography•              North America (U.S. and Canada)•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)•              Latin America (Brazil, Mexico, and Rest of Latin America)•              Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/influenza-vaccine-market-101896
Have a Look at Related Reports:Kidney Stone Management Market Size, Share & COVID-19 Impact Analysis, By Type (Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithonomy (PCNL) By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Regional Forecast, 2020-2027Dental Materials Market Size, Share & COVID-19 Impact Analysis, By Type (Metallic Biomaterials, Ceramic Biomaterials, Polymers, Natural Biomaterials, and Others), By Application (Implant, Prosthetics, and Orthodontics), By End User (Dental Product Manufacturers, Dental Laboratories, and Others), and Regional Forecast, 2020-2027Intensive Care Unit (ICU) Equipment Market Size, Share and Covid-19 Impact Analysis, By Product (Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others), By Patient (Adult and Pediatric), By Application (Neurology, Cardiology, Respiratory, Renal, Oncology, Trauma, and Others), By End-User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2020-2027Bone Graft Substitutes Market Size, Share & COVID-19 Impact Analysis, By Type (Autograft, Allograft, Demineralized Bone Matrix (DBM), Synthetic, and Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2027Cystic Fibrosis Market Size, Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, and Hospital Pharmacies), and Regional Forecast, 2020-2027
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/Influenza Vaccine-market-9421